Search your stocks

Share

Profile

DRREDDYDr. Reddy's Laboratories Ltd.

1321.4(-0.10%)

1W: +2.43%

1M: +8.88%

1Y: -78.84%

Financials

Charts

YoY Net Sales

Operating Margin

EPS Growth

Pros & Cons

POSITIVES

Revenue growth is consistent, reaching ₹8038.20 crore in Q2 FY2024, up from ₹6902.60 crore in Q3 FY2023.
Net profit rebounded to ₹1404.20 crore in Q4 FY2024, showing recovery from ₹1309.80 crore in Q3 FY2024.
Operating profit margin improved slightly, indicating better cost management and efficiency in operations.

NEGATIVES

Net profit dropped to ₹1341.90 crore in Q2 FY2024, down from ₹1482.20 crore in Q3 FY2023, signaling potential profitability pressures.
Expenses increased significantly, with material costs rising to 24.34% in Q1 FY2025, impacting overall profitability.
Tax expenses have fluctuated, reaching ₹575.50 crore in Q2 FY2024, which might affect net earnings going forward.

Quarterly Results Data

Field	Trend	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue		6,902.60	7,236.80	7,113.80	7,696.10	8,038.20	8,381.20	8,528.40	8,572.10
Expenses		5,305.10	5,626.60	5,709.60	6,006.60	6,434.40	6,661.30	7,050.80	6,957.60
Operating Profit		1,597.50	1,610.20	1,404.20	1,689.50	1,603.80	1,719.90	1,477.60	1,614.50
Other Income		315	216.20	197.50	187.20	307.50	150.20	522.10	290.30
Interest		35.30	39.40	59.30	59.80	75.70	81.70	65.60	83
Depreciation		375.50	373.50	367.70	380.60	397	471.40	454.70	476.10
Profit Before Tax		1,916.70	1,829.10	1,605.20	1,882.60	1,917.40	1,874.30	2,005.20	1,905
Tax		434.50	448.20	295.40	490.20	575.50	470.10	418.50	495.10
Net Profit		1,482.20	1,380.90	1,309.80	1,392.40	1,341.90	1,404.20	1,586.70	1,409.90
Eps in Rs		89.09	82.94	78.66	83.61	75.28	16.97	19.12	17.04